AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by AC Immune SA, a foreign private issuer, for the month of July 2019. The report, dated July 17, 2019, incorporates by reference a press release (Exhibit 99.1) into the company's active registration statements (Forms F-3 and S-8). The filing was signed by CEO Andrea Pfeifer and CFO Joerg Hornstein.
Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document. The text serves primarily as a cover sheet to distribute the attached press release.
Material Changes
The filing text does not provide details on material changes versus prior periods. The specific nature of the update is contained within the referenced press release (Exhibit 99.1), the content of which is not included in the input text.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided text. The document only confirms the existence of the press release and its incorporation into registration statements.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Press Release dated July 17, 2019) to understand the specific corporate event or announcement triggering this filing.
- Confirm the impact of the announcement on the company's active registration statements (333-224694, 333-227016, and 333-216539).
- Note that this document contains no standalone financial metrics; investors must refer to the full press release or subsequent periodic reports for financial data.